Table 4.

In-hospital and long-term adverse events according to RSS.

	All patients (n : 538)	RSS = 0 (n : 131)	RSS < 7 (n : 188)	RSS ≥ 7 (n: 219)	p value
In-hospital primary endpoint
Cardiac death	47 (8.7)	1 (0.8)a	2 (1.1)a	44 (20.1)b	<0.001
In-hospital secondary endpoint
MACE	152 (28.3)	16 (12.2)a	25 (13.3)a	111 (50.7)b	<0.001
Reinfarction	33 (6.1)	2 (1.5)a	2 (1.1)a	29 (13.2)b	<0.001
DHF	107 (19.9)	6 (4.6)a	19 (10.1)a	82 (37.4)b	<0.001
VT/VF	70 (13)	10 (7.6)a	10 (5.3)a	50 (22.8)b	<0.001
In-hospital safety endpoints	96 (17.8)	14 (10.7)a	19 (10.1)a	63 (28.8)b	<0.001
CIN	86 (16)	12 (9.2)a	17 (9)a	57 (26)b	<0.001
Bleeding	15 (2.8)	2 (1.5)	4 (2.1)	9 (4.1)	0.289
	All patients (n: 478)	RSS = 0 (n: 130)	0 < RSS < 7 (n : 185)	RSS ≥ 7 (n: 163)	p value
Long-term primary endpoint
Cardiac death	27 (5.6)	4 (3.1)a	7 (3.8)a	16 (9.8)b	0.017
Long-term secondary endpoint
MACE	102 (20.5)	14 (9.2)a	29 (14.6)a	59 (35.6)b	<0.001
Reinfraction	32 (6.7)	4 (3.1)a	10 (5.4)a	18 (11.1)b	0.032
Heart failure	15 (3.1)	2 (1.5)	5 (2.7)	8 (4.9)	0.236
Repeat revascularization	28 (5.9)	4 (3.1)a	7 (3.8)a	17 (10.4)b	0.009

Data are presented as n (%). Pearson chi-square test. Different lower case letters in a row indicate statistically significant difference between groups. CIN: contrast induced nephropathy, DHF: decompensated heart failure, MACE: major adverse cardiac events, RSS: residual SYNTAX score, and VT/VF: ventricular tachycardia/fibrillation.